Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000893220-95-000855
Filing Date
1995-12-04
Accepted
1995-12-04 00:00:00
Documents
4
Effectiveness Date
1995-12-23
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ONCOGENE SCIENCE S-8 63231
2 OPINION OF SAUL, EWING, REMICK & SAUL EX-5 2548
3 1993 INCENTIVE AND NON-QULIFIED STOCK OPTION PLAN EX-10 22544
4 CONSENT OF KPMG PEAT MARWICK EX-23.1 905
  Complete submission text file 0000893220-95-000855.txt   91022
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 033-64713 | Film No.: 95598794
SIC: 2835 In Vitro & In Vivo Diagnostic Substances